Relay Therapeutics, Inc. (RLAY)
17.88
+0.47
(+2.70%)
USD |
NASDAQ |
Oct 09, 16:00
17.62
-0.26
(-1.45%)
After-Hours: 06:05
Relay Therapeutics Free Cash Flow (Quarterly) : -54.11M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -54.11M |
| March 31, 2026 | -51.11M |
| December 31, 2025 | -44.87M |
| September 30, 2025 | -62.12M |
| June 30, 2025 | -55.29M |
| March 31, 2025 | -73.59M |
| December 31, 2024 | -57.87M |
| September 30, 2024 | -75.31M |
| June 30, 2024 | -65.84M |
| March 31, 2024 | -52.10M |
| December 31, 2023 | -89.31M |
| September 30, 2023 | -75.99M |
| June 30, 2023 | -70.10M |
| March 31, 2023 | -69.04M |
| December 31, 2022 | -59.40M |
| Date | Value |
|---|---|
| September 30, 2022 | -68.24M |
| June 30, 2022 | -58.95M |
| March 31, 2022 | -51.97M |
| December 31, 2021 | -40.59M |
| September 30, 2021 | -54.94M |
| June 30, 2021 | -28.52M |
| March 31, 2021 | 46.16M |
| December 31, 2020 | -35.34M |
| September 30, 2020 | -24.47M |
| June 30, 2020 | -21.26M |
| March 31, 2020 | -23.35M |
| December 31, 2019 | -23.36M |
| September 30, 2019 | -19.89M |
| June 30, 2019 | -16.93M |
| March 31, 2019 | -13.96M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -7.588M |
| TG Therapeutics, Inc. | 38.97M |
| Karyopharm Therapeutics, Inc. | -24.93M |
| Spyre Therapeutics, Inc. | -70.16M |
| Akebia Therapeutics, Inc. | 2.446M |